Dachaigh › Myeloma iomaill
Sgrùdaidhean clionaigeach Myeloma iomaill a’ fastadh anns na SA
Tha 239 sgrùdaidhean airson Myeloma iomaill a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- New York City, NY60 sgrùdaidhean
- Boston, MA42 sgrùdaidhean
- Atlanta, GA42 sgrùdaidhean
- Houston, TX38 sgrùdaidhean
- Durham, NC37 sgrùdaidhean
- Nashville, TN32 sgrùdaidhean
- Denver, CO27 sgrùdaidhean
- Rochester, MN24 sgrùdaidhean
- St. Louis, MO24 sgrùdaidhean
- Columbus, OH24 sgrùdaidhean
- Baldwin Park, CA23 sgrùdaidhean
- Edison, NJ22 sgrùdaidhean
- Chicago, IL22 sgrùdaidhean
- Washington, DC22 sgrùdaidhean
- Seattle, WA22 sgrùdaidhean
- Charlotte, NC21 sgrùdaidhean
- Milwaukee, WI21 sgrùdaidhean
- Miami, FL21 sgrùdaidhean
- Salt Lake City, UT21 sgrùdaidhean
- Queens, NY20 sgrùdaidhean
- Detroit, MI19 sgrùdaidhean
- Birmingham, AL18 sgrùdaidhean
- Jacksonville, FL18 sgrùdaidhean
- Cincinnati, OH17 sgrùdaidhean
- Los Angeles, CA17 sgrùdaidhean
- Dallas, TX17 sgrùdaidhean
- Philadelphia, PA16 sgrùdaidhean
- Phoenix, AZ16 sgrùdaidhean
- Omaha, NE16 sgrùdaidhean
- Cleveland, OH16 sgrùdaidhean
- San Francisco, CA15 sgrùdaidhean
- Tampa, FL15 sgrùdaidhean
- Cedar Rapids, IA15 sgrùdaidhean
- Clifton, NJ14 sgrùdaidhean
- New Haven, CT14 sgrùdaidhean
- Winston-Salem, NC14 sgrùdaidhean
- New Rochelle, NY14 sgrùdaidhean
- Irvine, CA14 sgrùdaidhean
- Indianapolis, IN13 sgrùdaidhean
- Tacoma, WA13 sgrùdaidhean
Le stàit
- Alabama22 sgrùdaidhean
- Arizona28 sgrùdaidhean
- Arkansas9 sgrùdaidhean
- California70 sgrùdaidhean
- Colorado37 sgrùdaidhean
- Connecticut18 sgrùdaidhean
- Delaware4 sgrùdaidhean
- Florida55 sgrùdaidhean
- Georgia50 sgrùdaidhean
- Idaho3 sgrùdaidhean
- Illinois31 sgrùdaidhean
- Indiana19 sgrùdaidhean
- Iowa17 sgrùdaidhean
- Kansas12 sgrùdaidhean
- Kentucky15 sgrùdaidhean
- Louisiana9 sgrùdaidhean
- Maine3 sgrùdaidhean
- Maryland25 sgrùdaidhean
- Massachusetts44 sgrùdaidhean
- Michigan26 sgrùdaidhean
- Minnesota30 sgrùdaidhean
- Missouri27 sgrùdaidhean
- Montana5 sgrùdaidhean
- Nebraska18 sgrùdaidhean
- New Hampshire4 sgrùdaidhean
- New Jersey38 sgrùdaidhean
- New Mexico5 sgrùdaidhean
- New York75 sgrùdaidhean
- North Carolina52 sgrùdaidhean
- North Dakota5 sgrùdaidhean
- Ohio46 sgrùdaidhean
- Oklahoma3 sgrùdaidhean
- Oregon20 sgrùdaidhean
- Pennsylvania23 sgrùdaidhean
- Rhode Island6 sgrùdaidhean
- Sgìre Cholumbia10 sgrùdaidhean
- South Carolina9 sgrùdaidhean
- South Dakota3 sgrùdaidhean
- Tennessee32 sgrùdaidhean
- Texas53 sgrùdaidhean
- Utah21 sgrùdaidhean
- Virginia20 sgrùdaidhean
- Washington30 sgrùdaidhean
- West Virginia3 sgrùdaidhean
- Wisconsin28 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06976476Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06948084Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06465316A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06055894Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06398457Limited-duration Teclistamab
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05932680Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06904066Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06630104A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07582432A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
A’ fastadhÌre 2
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06679829A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07589634A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05519085The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07285044SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07850284A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07391657A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07409246A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05652335A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT04973605Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT02682667Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
A’ fastadhÌre 2
Aoisean 18 gu 72 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT03412877Tissue Collection for Studies of Lymph Cancer
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT01676805A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05201781A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07149857A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07258511Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
A’ fastadhÌre 2
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06052826Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.